Chlorpyrifos toxicity causing delayed myeloneuropathy

Ostwal, Piyush; Dabadghao, Varsha S.; Sharma, Suresh K.; Dhakane, Ajinkya B.
October 2013
Annals of Indian Academy of Neurology;Oct2013, Vol. 16 Issue 4, p736
Academic Journal
Case Study
The article focuses on the case of a 25-year-old man diagnosed with Chlorpyrifos toxicity, who before admission consumed about 50 milliliters of pesticide preparation containing chlorpyrifos 50 percent and was managed with stomach wash, injection atropine and other supportive medical care. The patient experienced mild bladder symptoms in the form of urgency after the medical treatment.


Related Articles

  • Multiple myeloma: treatment-related peripheral neuropathy. Dowling, Maura; Kelly, Mary; Meenaghan, Teresa // British Journal of Nursing;12/13/2012, Vol. 21 Issue 22, p1325 

    The authors discuss treatment-related peripheral neuropathy (PN), which is caused by the use of the proteasome inhibitor bortezomib and the immunomodulator thalidomide to treat multiple myeloma (MM). PN caused by bortezomib can result in neuropathic pain and sensory impairment, while...

  • Unilateral common peroneal nerve palsy following renal transplantation: A case report of tacrolimus neurotoxicity. Jain, A.; Mathew, P. J.; Modi, M.; Mangal, K. // Journal of Postgraduate Medicine;Apr-Jun2011, Vol. 57 Issue 2, p126 

    Neurologic complications are not uncommon in renal transplant recipients. Acute femoral neuropathy, lumbosacral plexopathy, and sciatic neuropathy have been reported after kidney transplantation probably due to perioperative nerve compression and ischemia. To the best of our knowledge, common...

  • Bortezomib-induced peripheral neurotoxicity: an update. Argyriou, Andreas; Cavaletti, Guido; Bruna, Jordi; Kyritsis, Athanasios; Kalofonos, Haralabos // Archives of Toxicology;Sep2014, Vol. 88 Issue 9, p1669 

    This review paper provides a critical exploration of updates concerning the spectrum of characteristics and treatment options of bortezomib-induced peripheral neuropathy (BIPN). Emphasis is given on pathogenesis issues. Although the mechanism underlying BIPN still remains elusive, it is...

  • Treatment options for extra-intestinal manifestations of inflammatory bowel disease vary, but remain limited for some.  // Drugs & Therapy Perspectives;Jun2013, Vol. 29 Issue 6, p166 

    Extra-intestinal manifestations (EIMs) of inflammatory bowel disease can affect many different organ systems. Pharmacological treatment options include corticosteroids, anaesthetics, antiresorptives, immunosuppressants, immunomodulators and biological agents, depending on the individual...

  • Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature. Dat Ngo; Patel, Samit; Eun Jeong Kim; Brar, Rondeep; Koontz, Michael Z. // Journal of Oncology Pharmacy Practice;Aug2015, Vol. 21 Issue 4, p296 

    Severe nelarabine neurotoxicity in a patient who received concurrent intrathecal (IT) chemotherapy is reported. A 37-year-old Caucasian woman with a history of T -cell lymphoblastic lymphoma was admitted for relapsed disease. She was originally treated with induction chemotherapy followed by an...

  • Anterior Ä°nterosseöz Sinir Sendromu. Karaahmet, Özgür Zeliha; Ünlü, Ece; Umay, Ebru; Karataş, Gülşah; Çakcı, Aytül // Journal of Physical Medicine & Rehabilitation Sciences / Fizikse;Mar2013, Vol. 16 Issue 1, p39 

    Anterior interosseous nerve syndrome (AINS) is rare that occurs about 1% in all upper-extremity peripheral neuropathies. In 1948, Personage and Turner described neuralgic amyotrophy in a series of five cases, characterized by the anterior interosseous nerve palsy for the first time. Later, AISS...

  • Chronic dysimmune neuropathy : A subclassification based upon the clinical features of 102 patients. Busby, Mark; Donaghy, Michael // Journal of Neurology;Jun2003, Vol. 250 Issue 6, p714 

    The Chronic Dysimmune neuropathies (CDN) are a clinically heterogeneous group of polyneuropathies united by their presumed immune mediated aetiology. At present such neuropathies are classified as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) and the...

  • Periferik Nöropati ile Isaacs Sendromu (Nöromiyotoni) BirlikteliÄŸi. ÇELİK, Canan; MANDIROĞLU, Sibel; UÇAN, Halil; SEVGİ, Eser Başak // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;Dec2013, Vol. 59 Issue 4, p353 

    Isaacs’s syndrome (neuromyotonia), which is characterized by peripheral nerve hyperexcitability, is a rare condition of spontaneous and continuous muscle fibre activity. This syndrome is associated with myokymia, muscle cramps and stiffness, delayed muscle relaxation after contraction,...

  • Guillain-Barré syndrome. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p351 

    An encyclopedia entry for "Guillain-Barré syndrome" is presented. It refers to a rare condition that affects the peripheral nervous system, resulting in weakness, particularly in the limbs. It is believed to be caused by an allergic reaction to an infection, usually viral in nature, wherein...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics